Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Model Medicines logo — Precision Medicines, Broad Applications

Model Medicines

Precision Medicines, Broad Applications

Founded 2019 United States La Jolla, United States 15 employees Seed Total: $4.10M AI, Biotechnology +2

General Information

Company Name Model Medicines
Founded Year 2019
Location United States La Jolla, United States +1
Employees 15
Industries AI, Biotechnology, Pharmaceutical +1
Funding Stage Seed
Social

Get notified when Model Medicines moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

AI Insight

Bounce Watch AI
2 months ago

Model Medicines recently enhanced its industry visibility and engagement through the participation of Daniel Haders II, Ph.D. at Fierce Biotech Week in Boston in May 2026. This presence at a key industry event signals the company's ongoing commitment to networking and establishing its profile within the competitive biotechnology landscape. Such strategic appearances are vital for a Seed-stage company aiming to build recognition and attract potential partners or investors for its AI-driven drug discovery programs.

Signal Types
Industry Engagement Market Presence
Strategic Labels
Industry Engagement Market Visibility Strategic Networking
Next Move: Fundraising
·
Impact: 6/10
·
Ideal For: AI-driven Biotech VCs – Early Stage

About Model Medicines

Model Medicines, founded in 2019, is an AI-driven, human health company dedicated to utilizing AI to model all of chemistry and human biology in order to expedite the development of life-changing drugs. With a focus on AI-drug discovery, the company has already amassed an impressive portfolio of 182 compounds for 26 targets. Their robust pipeline includes patent-pending therapeutics for a wide array of health concerns such as oncology, infectious diseases, gastric disorders, neurological disorders, and weight disorders. Based in La Jolla, CA, the company recently secured a notable $4.10M Seed Round investment on 01 February 2021, with participation from influential investors including Nex Cubed, 8VC, Irving Investors, Triton Funds, Particle Accelerator Limited (ParticleX), Carter Comstock, and Friedman BioVentures. Model Medicines' pioneering approach positions it at the forefront of the biotechnology and pharmaceutical industries, offering promising prospects for innovative drug development propelled by AI technology. This startup holds substantial potential for groundbreaking contributions to the healthcare landscape.

Taxonomy: AI-driven healthcare, Drug discovery, Chemistry modeling, Biology modeling, Therapeutics development, Oncology drugs, Infectious disease drugs, Gastric disorder drugs, Neurological disorder drugs, Weight disorder drugs, Patent-pending drugs, Life sciences, La Jolla, CA, Health technology

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 7
Investor Investor Investor Investor
•••• •••• 		01 Feb 2021

Model Medicines Alternatives & Competitors

Model Medicines vs
Oklahoma Medical Research Foundation
Oklahoma Medical Research Foundation United States

Discoveries that make a difference

Grant
496 employees
Biotechnology
Model Medicines vs
Frontier Medicines
Frontier Medicines United States

Frontier Medicines is a biopharmaceutical company that “drugs the undruggable” to transform patients...

Series C
77 employees
Biopharma, Biotechnology
Model Medicines vs
Entact Bio
Entact Bio United States

Creating new medicines by enhancing protein function

Series Unknown
42 employees
Biopharma, Biotechnology

FAQ About Model Medicines

Precision Medicines, Broad Applications
Model Medicines was founded in 2019.
Model Medicines is headquartered in La Jolla, United States.
Model Medicines operates in the following industries: AI, Biotechnology, Pharmaceutical, Machine Learning.
Model Medicines has approximately 15 employees.
Model Medicines has completed 1 funding round, raising a total of $4.10M. The latest funding stage is Seed.
Top alternatives and competitors to Model Medicines include Oklahoma Medical Research Foundation, Frontier Medicines, Entact Bio, Sanjivani Paranteral Ltd, Gate Bioscience. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Model Medicines and Oklahoma Medical Research Foundation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Model Medicines and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy